Navigation Links
Vestara Announces Strategic Agreement with Leading Contract Services Company Novation
Date:8/26/2009

Vestara announced today a strategic agreement with leading contract services company Novation, to provide the nearly 2,000 VHA and University HealthSystem Consortium (UHC) and nearly 14,000 members of Provista, LLC with the only automated pharmaceutical waste management solution in the industry. Novation's vast network includes acute hospitals and systems, academic medical centers, ambulatory care and physician clinics, home health and long-term care facilities.

Irvine, CA (PRWEB) August 26, 2009 -- Vestara announced today a strategic agreement with leading contract services company Novation, to provide the nearly 2,000 VHA and University HealthSystem Consortium (UHC) and nearly 14,000 members of Provista, LLC with the only automated pharmaceutical waste management solution in the industry. Novation's vast network includes acute hospitals and systems, academic medical centers, ambulatory care and physician clinics, home health and long-term care facilities.

This strategic agreement presents the members with a make-sense solution for pharmaceutical waste management that controls costs and facilitates environmental responsibility. Vestara and Novation both strive to provide the healthcare industry with effective solutions that not only make economic sense for their clients, but that also contribute to preserving the environment.

Vestara's EcoRex® Automated Pharmaceutical Waste Management System utilizes barcode technology already widely used in hospitals to track drug utilization that prevents medication errors and a proprietary, continuously updated database of more than 180,000 National Drug Code (NDC) products, to instantly categorize pharmaceutical waste at time of presentation. By automating the identification and sorting of different types of residual drugs, empty containers, and each hospital's unique admixtures, EcoRex® eliminates the human error and potential cross contamination inherent in manual sorting of pharmaceutical waste to reduce negative impact on the environment. Just as important, relevant data and an audit trail are provided in the form of comprehensive reports for client records.

About Vestara
Vestara (www.vestara.com), headquartered in Irvine, CA, provides proprietary technology to automatically identify, sort, and segregate hazardous and non-hazardous pharmaceutical waste into proper waste streams. Vestara's solutions not only assure clients will be compliant with all federal and state laws, but that they will experience a more efficient health system workforce and true cost savings in managing pharmaceutical waste. Most importantly, clients will play a critical role in preserving our precious environment.

About Novation
Founded in 1998, Novation is the leading health care contracting services company for more than 2,500 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances and nearly 14,000 members of Provista, LLC. Novation offers its customers contract development and management, supply chain data and measurement, and industry knowledge and advocacy. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 500 suppliers. VHA, UHC and Provista members used Novation contracts to purchased nearly $35 billion in 2008.

# # #

Read the full story at http://www.prweb.com/releases/2009/08/prweb2793834.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. EPIX Pharmaceuticals, Inc. Announces the PRX-00023 Therapeutics CNS Program in Phase 2b/3 Will Be Part of the Intellectual Property Offered for Sale at the September 30, 2009 Auction
2. Regado Biosciences Announces First Patient Enrolled In Phase 1 Study Of Subcutaneously Administered Reg1 Anticoagulation System
3. Portola Pharmaceuticals Announces Two Oral Presentations on Elinogrel at European Society of Cardiology Congress 2009
4. Cell Therapeutics, Inc. Announces Closing of Registered Offering of $30 Million of Preferred Stock and Warrants
5. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
6. Cell Therapeutics, Inc. Announces Institutional Investor Purchases $30 Million of Preferred Stock and Warrants
7. Immucor Announces 2 Million Share Increase to Stock Repurchase Program
8. Epix Pharmaceuticals, Inc. Announces the PRX-08066 Therapeutics Program in Phase 2 for Respiratory Indication Will Be Part of The Intellectual Property Offered for Sale at the September 30, 2009 Auction
9. CryoLife Announces Implants of First FDA-Cleared SynerGraft(R) Processed Human Cardiac Patch Material
10. Cord Blood America Announces Preferred Pricing for Blue Cross of Northeastern Pennsylvania Members
11. Imagenetix, Inc. Announces Interview With Bloomberg Radio
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
(Date:12/7/2016)... NE (PRWEB) , ... December 07, 2016 , ... ... systems integration, today announced that it has become a Wonderware Certified System Integrator ... System Integrator Partner by Schneider Electric Software. , “The System Integrator Partner certification ...
(Date:12/7/2016)... 2016  Biocom, the association for the California ... passage of 21 st Century Cures legislation in Congress. ... a 392-26 vote and in the Senate on December 7 ... Joe Panetta , president & CEO of Biocom: ... to millions of patients around the world. The measure culminates ...
(Date:12/7/2016)... ARBOR, Mich. , Dec. 7, 2016  Lycera ... modulatory medicines, announced today the initiation of a Phase ... LYC-30937- E nteric C oated, in patients with ... is estimated to affect as many as 7.5 million people ... approximately 1.5 - 3 million cases being diagnosed as ...
Breaking Biology Technology:
(Date:11/29/2016)... Nov. 29, 2016 BioDirection, a privately held ... for the objective detection of concussion and other traumatic ... successfully completed a meeting with the U.S. Food and ... test Pre-Submission Package. During the meeting company representatives reviewed ... a precursor to commencement of a planned pilot trial. ...
(Date:11/22/2016)... November 22, 2016 According to the new market ... Print, Face, Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact ... MarketsandMarkets, the market is expected to grow from USD 10.74 Billion in ... 16.79% between 2016 and 2022. Continue Reading ... ...
(Date:11/17/2016)... it has just released a new white paper authored by Zettar that covers the ... transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be a complicated endeavor ...
Breaking Biology News(10 mins):